Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 1;14(2):182-190.
doi: 10.4103/ijmy.ijmy_47_25. Epub 2025 Jun 20.

Molecular Characterization of Mycobacterium Tuberculosis in HIV Patients Receiving Antiretroviral Drugs in Cameroon

Gerades Dely Djoufack  1   2 , Lem Edith Abongwa  1   2   3 , Allan Olayemi Campbell  1   2 , Julian Sydney Olufemi Campbell  1   2 , Kabir Gorden  1   2 , Jean M Mendimi Nkodo  4 , Christian Happi  1   2 , Onikepe Folarin  1   2
Affiliations
Free article

Molecular Characterization of Mycobacterium Tuberculosis in HIV Patients Receiving Antiretroviral Drugs in Cameroon

Gerades Dely Djoufack et al. Int J Mycobacteriol. .
Free article

Abstract

Background: Tuberculosis (TB) remains a leading cause of mortality among people living with HIV/AIDS, who face a tenfold higher risk of Mycobacterium tuberculosis (MTB) infection. TB-HIV coinfection complicates disease management due to drug interactions, overlapping toxicities, immune reconstitution inflammatory syndrome, and high treatment burdens, potentially driving drug resistance. The emergence of resistant MTB further exacerbates this challenge. This study evaluated the drug resistance profile of MTB in TB-confirmed samples from HIV-positive patients.

Methods: An analytical cross-sectional study was conducted on 216 sputum samples from HIV patients on antiretroviral therapy at Jamot Hospital, Yaoundé, Cameroon (June-September 2022). Two consecutive samples per patient underwent fluorescent microscopy (Auramine-Rhodamine stain) and TB-Loop-Mediated Isothermal Amplification. DNA was extracted using the GenoLyse® kit (Hain Lifescience, Germany), and drug resistance profiles were assessed via GenoType® MTBDRplus and MTBDRsl line probe assays.

Results: TB was confirmed in 12.04% (26/216) of participants. Rifampicin (RIF) and isoniazid (INH) resistance were each detected in 50% (13/26) of cases, with 23% (6/26) exhibiting multidrug-resistance (MDR). Predominant mutations included rpoB MUT2B (15.38%) for RIF and inhA MUT2A (23.06%) for INH. Second-line resistance analysis revealed 61.54% (8/13) resistance to kanamycin (KAN)/amikacin (AMK)/viomycin, 7.69% (1/13) to AMK/capreomycin/viomycin, and 7.69% (1/13) to KAN. Notably, 61.54% (8/13) lacked the rrs wild-type probe, indicating resistance to injectable TB drugs.

Conclusion: High MDR-TB prevalence was observed among HIV-TB coinfected patients, underscoring the urgent need for enhanced resistance surveillance and optimized treatment strategies in TB/HIV-endemic regions like Cameroon. Further research is warranted to elucidate HIV's role in driving TB drug resistance.

Keywords: Coinfection; molecular characterization; tuberculosis.

PubMed Disclaimer

References

R EFERENCES

    1. Meskini M, Madadi N, Ahmadi K, Vaziri F, Fateh A, Siadat SD. Tuberculosis prevention, diagnosis, and treatment financial profile during 2006-2021: PART A. Cost Eff Resour Alloc 2023;21:68.
    1. MacNeil A, Glaziou P, Sismanidis C, Date A, Maloney S, Floyd K. Global epidemiology of tuberculosis and progress toward meeting global targets – Worldwide, 2018. MMWR Morb Mortal Wkly Rep 2020;69:281–5.
    1. Khan AH, Nagoba BS, Shiromwar SS. A critical review of risk factors influencing the prevalence of extensive drug-resistant tuberculosis in India. Int J Mycobacteriol 2023;12:372–9.
    1. World Health Organization. WHO Consolidated Guidelines on Tuberculosis: Module 1: Prevention. Geneva: WHO; 2022. Available from: https://www.who.int/publications/i/item/9789240048126 . [Last accessed on 2025 Mar 08].
    1. Habous M, Elimam M, AlDabal L, Chidambaran B, AlDeesi Z. Pattern of primary tuberculosis drug resistance and associated risk factors at Dubai health authority in Dubai. Int J Mycobacteriol 2020;9:391–6.

MeSH terms

Substances

LinkOut - more resources